Jeff Yass’s Olema Pharmaceuticals OLMA Stock Holding History

Jeff Yass’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.28M	Sell	182,300 -189,900	-51%	-$2.54M	﹤0.01%	6180
2026 Q1	$5.55M	Sell	372,200 -31,800	-8%	-$708K	﹤0.01%	4053
2025 Q4	$10.1M	Buy	+404,000	New	+$7.19M	﹤0.01%	3024
2024 Q4	–	Sell	-16,400	Closed	-$196K	–	12917
2024 Q3	$196K	Sell	16,400 -8,100	-33%	-$104K	﹤0.01%	10493
2024 Q2	$265K	Sell	24,500 -8,500	-26%	-$92.2K	﹤0.01%	9737
2024 Q1	$374K	Sell	33,000 -30,100	-48%	-$388K	﹤0.01%	9189
2023 Q4	$885K	Buy	63,100 +33,800	+115%	+$454K	﹤0.01%	7287
2023 Q3	$362K	Buy	29,300 +14,600	+99%	+$149K	﹤0.01%	8956
2023 Q2	$133K	Buy	+14,700	New	+$88.8K	﹤0.01%	10696
2022 Q4	–	Sell	-11,200	Closed	-$31K	–	13310
2022 Q3	$31K	Sell	11,200 -27,000	-71%	-$115K	﹤0.01%	12432
2022 Q2	$155K	Sell	38,200 -32,700	-46%	-$104K	﹤0.01%	10984
2022 Q1	$302K	Buy	70,900 +46,400	+189%	+$256K	﹤0.01%	10263
2021 Q4	$229K	Buy	+24,500	New	+$508K	﹤0.01%	11154

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jeff Yass's OLMA Position: Q2 2026 in Review

Jeff Yass reduced its Olema Pharmaceuticals (OLMA) stake by 56% in Q2 2026, selling an estimated $2.16M and leaving 124,952 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #7060.

Jeff Yass first reported a position in OLMA in Q4 2020 and has held it in 20 quarters since. The position peaked at $4.26M in Q1 2026. 183 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

Jeff Yass held 124,952 shares of Olema Pharmaceuticals worth $1.56M as of Q2 2026.
Jeff Yass sold 160,930 Olema Pharmaceuticals shares in Q2 2026, an estimated $2.16M.
Olema Pharmaceuticals made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #7060 holding.
Jeff Yass first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 20 quarters since.
Jeff Yass's Olema Pharmaceuticals position peaked at $4.26M in Q1 2026.
183 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.